These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 15801034

  • 1. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
    Mor A, Bingham CO, Barisoni L, Lydon E, Belmont HM.
    J Rheumatol; 2005 Apr; 32(4):740-3. PubMed ID: 15801034
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K.
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
    Nakahigashi K, Egawa G, Miyachi Y, Kabashima K.
    Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
    Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA.
    Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA, Murray KJ.
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract] [Full Text] [Related]

  • 15. Spontaneous resolution of lupus nephritis following withdrawal of etanercept.
    Yahya TM, Dhanyamraju S, Harrington TM, Prichard JW.
    Ann Clin Lab Sci; 2013 Dec; 43(4):447-9. PubMed ID: 24247804
    [Abstract] [Full Text] [Related]

  • 16. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Kang MJ, Lee YH, Lee J.
    J Korean Med Sci; 2006 Oct; 21(5):946-9. PubMed ID: 17043436
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.